Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: A multicentre, randomized, double-blind, placebo-controlled study

Journal of Viral Hepatitis

Volumn 16, Issue 2, 2009, Pages 94-103

  Xu, W M ^a,l   Cui, Y T ^b   Wang, L ^c   Yang, H ^d   Liang, Z Q ^e   Li, X M ^f   Zhang, S L ^g   Qiao, F Y ^h   Campbell, F ⁱ   Chang, C N ^j   Gardner, S ^j   Atkins, M ^k  

^a Shanghai Infectious Disease Hospital   (China)

^b Beijing United Family Hospital   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e SOUTHWEST HOSPITAL   (China)

^f SUN YAT SEN UNIVERSITY   (China)

^g Xian Communication University   (China)

^h Tongji Hospital   (China)

ⁱ GLAXOSMITHKLINE   (United Kingdom)

^j GLAXOSMITHKLINE   (United States)

^k ST MARY S HOSPITAL   (United Kingdom)

^l Shanghai Skin Disease and STD Hospital   (China)

more..

Author keywords

Chronic hepatitis B; HBIg; Hepatitis B virus; Lamivudine; Vaccination

Indexed keywords

H B VAX II; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; LAMIVUDINE; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HEPATITIS B; HUMAN; HYDRAMNIOS; HYPERBILIRUBINEMIA; INFECTION PREVENTION; JAUNDICE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THIRD TRIMESTER PREGNANCY; VIRUS TRANSMISSION;

ADULT; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CHEMOPREVENTION; DOUBLE-BLIND METHOD; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LAMIVUDINE; PLACEBOS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TREATMENT OUTCOME;

EID: 59149096271     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.01056.x     Document Type: Article

References (24)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997 337 : 1733 1745.
2. Stevens CE, Beasley RP, Tsui J, Lee W-C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975 292 : 771 774.
3. Stevens CE, Troy PT, Tong MJ et al. Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization. JAMA 1985 253 : 1740 1745.
4. Andre FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994 44 : 144 151.
5. Ghendon Y. WHO strategy for the global elimination of new cases of hepatitis B. Vaccine 1990 8 : S129 S133.
6. Grosheide PM, del Canho R, Heijtink RA et al. Passive-active immunisation in infants of hepatitis B e antigen-positive mothers. Am J Dis Child 1993 147 : 1316 1320.
7. Lo KJ, Tsai YT, Lee SD et al. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan. Hepatogastroenterology 1985 32 : 65 68.
8. Farmer K, Gunn T, Woodfield DG. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers. NZ Med J 1987 100 : 412 414.
9. Polakoff S, Vandervelde EM. Immunisation of neonates at high risk of hepatitis B in England and Wales: national surveillance. BMJ 1988 297 : 249 253.
10. del Canho R, Grosheide PM, Schalm SW, de Vries RR, Heijtink RA. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 1994 20 : 483 486.
11. del Canho R, Grosheide PM, Maze JA et al. Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997 15 : 1624 1630.
12. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprohpylaxis for Hepatitis B: characteristics of maternal Hepatitis B virus as risk factors. Clin Infect Dis 1998 27 : 100 106.
13. Ip HMH, Lelie PN, Wong VCW, Kuhns MC, Reesink HW. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989 333 : 406 410.
14. Li XM, Yang YB, Hou HY et al. Interruption of HBV intrauterine transmission: a clinical study. World J Gastroenterol 2003 9 : 1501 1503.
15. van Nunen AB, de Man RA, Heijtink RA, Niesters HGM, Schalm SW. Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients. J Hepatol 2000 32 : 1040 1042.
16. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003 10 : 294 297.
17. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004 10 (6 910 912.
18. McGowan JP, Shah SS. Prevention of perinatal HIV transmission during pregnancy. J Antimicrob Chemother 2000 46 : 657 668.
19. Mofenson LM, Munderi P. Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants. J Acquir Immune Defic Syndr 2002 30 : 200 215.
20. Newell ML. Prevention of mother-to-child transmission of HIV: challenges for the current decade. Bull World Health Organ 2001 79 : 1138 1144.
21. Li XM, Yang YB, Hou HY et al. Interruption of HBV intrauterine transmission: a clinical study. World J Gastroenterol 2003 9 (7 1501 1503.
22. Lai CL, Dienstag J, Schiff E et al. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin Infect Dis 2003 36 : 687 696.
23. Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral pregnancy registry international interim report for 1 January 1989-31 January 2007. Wilmington, NC : Registry Coordinating Center, 2007. Available at: http://www.APRegistry.com.
24. Qian X, Smith H, Zhou L, Liang J, Garner P. Evidence-based obstetrics in four hospitals in China: an observational study to explore clinical practice, women's preferences and provider's views. BMC Pregnancy Childbirth 2001 1 (1 1.